Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders

ROCKVILLE, Md., May 24, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that it will hold its 2011 Annual Meeting of Stockholders on Thursday, June 16, 2011, in Rockville, Maryland.  The record date for the Annual Meeting is April 20, 2011.  Only stockholders of record as of the close of business on April 20, 2011 may vote at the meeting or any adjournment thereof.  Vanda's proxy statement and annual report are available at www.proxyvote.com and includes the time and location of the Annual Meeting, as well as a description of the matters to be considered.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
[email protected]

SOURCE Vanda Pharmaceuticals Inc.

Suggested Articles

Novo is working on a once-weekly basal insulin that could cut down on injections for people with Type 2 diabetes, and the phase 2 data look promising.

The money will support work on a biologic drug cocktail that Lumen thinks can be a scalable, inexpensive fix for gastrointestinal symptoms.

The readouts link the oral oxidative phosphorylation blocker imeglimin to near- and long-term improvements when given as a monotherapy and in combos.